Sander R. Dubovy

8.7k total citations · 2 hit papers
232 papers, 5.9k citations indexed

About

Sander R. Dubovy is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Sander R. Dubovy has authored 232 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Ophthalmology, 77 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Epidemiology. Recurrent topics in Sander R. Dubovy's work include Ocular Oncology and Treatments (62 papers), Glaucoma and retinal disorders (38 papers) and Corneal Surgery and Treatments (38 papers). Sander R. Dubovy is often cited by papers focused on Ocular Oncology and Treatments (62 papers), Glaucoma and retinal disorders (38 papers) and Corneal Surgery and Treatments (38 papers). Sander R. Dubovy collaborates with scholars based in United States, Egypt and Belgium. Sander R. Dubovy's co-authors include William J. Feuer, Harry W. Flynn, Philip J. Rosenfeld, Janet L. Davis, Geeta A. Lalwani, Carol L. Karp, Anne E. Fung, Anat Galor, Carmen A. Puliafito and Stephan Michels and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Sander R. Dubovy

211 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

2007 802 citations Anne E. Fung, Geeta A. Lalwani et al. American Journal of Ophthalmology profile →
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

2009 719 citations Geeta A. Lalwani, Philip J. Rosenfeld et al. American Journal of Ophthalmology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sander R. Dubovy	4.6k	3.2k	603	596	582	232	5.9k
James J. Augsburger	6.0k 1.3×	1.8k 0.6×	1.4k 2.4×	755 1.3×	1.6k 2.7×	269	7.2k
Pravin U. Dugel	6.3k 1.4×	4.4k 1.4×	1.4k 2.3×	472 0.8×	129 0.2×	151	7.1k
Klaus‐Peter Steuhl	1.1k 0.2×	1.1k 0.3×	305 0.5×	264 0.4×	272 0.5×	95	2.3k
Manfred Zierhut	3.6k 0.8×	438 0.1×	293 0.5×	484 0.8×	177 0.3×	227	4.9k
Seymour Brownstein	1.3k 0.3×	570 0.2×	407 0.7×	334 0.6×	561 1.0×	173	2.8k
Carl P. Herbort	5.0k 1.1×	525 0.2×	251 0.4×	645 1.1×	111 0.2×	223	5.7k
Masahiko Usui	2.5k 0.5×	433 0.1×	384 0.6×	511 0.9×	172 0.3×	145	3.4k
Matthias Becker	1.9k 0.4×	769 0.2×	300 0.5×	195 0.3×	102 0.2×	115	2.6k
Phuc LeHoang	4.1k 0.9×	269 0.1×	292 0.5×	1.0k 1.7×	491 0.8×	201	5.7k
T. Hoang–Xuan	1.1k 0.2×	1.1k 0.3×	343 0.6×	763 1.3×	172 0.3×	115	2.4k

Countries citing papers authored by Sander R. Dubovy

Since Specialization

Citations

This map shows the geographic impact of Sander R. Dubovy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander R. Dubovy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander R. Dubovy more than expected).

Fields of papers citing papers by Sander R. Dubovy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander R. Dubovy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander R. Dubovy. The network helps show where Sander R. Dubovy may publish in the future.

Co-authorship network of co-authors of Sander R. Dubovy

This figure shows the co-authorship network connecting the top 25 collaborators of Sander R. Dubovy. A scholar is included among the top collaborators of Sander R. Dubovy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander R. Dubovy. Sander R. Dubovy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Mengxi, Alessandro Berni, Jeremy Liu, et al.. (2025). Real-World Experience With Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration. American Journal of Ophthalmology. 281. 31–41.

Dubovy, Sander R., et al.. (2024). Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia. The Ocular Surface. 33. 1–10. 2 indexed citations

Patel, Nimesh A., Jorge A. Fortun, Philip J. Rosenfeld, et al.. (2024). Faricimab in Previously Treated Eyes With Neovascular Age-Related Macular Degeneration: An Assessment of Durability and Treatment Outcomes. Ophthalmic surgery, lasers & imaging retina. 55(9). 504–509. 2 indexed citations

Foley, Lesley M., Sander R. Dubovy, Basil K. Williams, et al.. (2024). Progressive anterior segment involvement of an infant with corneoscleral juvenile xanthogranuloma refractory to topical steroids. American Journal of Ophthalmology Case Reports. 36. 102205–102205.

Meyer, Benjamin I., Mohammed Raja, Jaylou M. Velez Torres, et al.. (2024). To do or not to do: Large-dose steroid treatment for severe vision loss secondary to compressive inflammatory optic neuropathy in the setting of invasive fungal sinusitis. American Journal of Ophthalmology Case Reports. 36. 102183–102183.

Venkateswaran, Nandini, et al.. (2024). Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology. 60(2). e253–e262.

Choi, Catherine J., et al.. (2022). A single-institution review of lacrimal gland biopsies between 1962 and 2017. Orbit. 42(2). 148–156. 2 indexed citations

Magistri, Marco, Lanie E. Happ, Jeremy Ramdial, et al.. (2021). The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. Cancer Research Communications. 1(1). 1–16. 8 indexed citations

Patel, Nimesh A., Kenneth C. Fan, Nicolas A. Yannuzzi, et al.. (2021). <b><i>Agrobacterium radiobacter</i></b> Endophthalmitis Associated with Baerveldt Tube Exposure. Case Reports in Ophthalmology. 12(3). 921–926. 1 indexed citations

10.

Monsalve, Pedro, George W. Elgart, Carol L. Karp, et al.. (2019). Atypical Fibroxanthoma Affecting the Ocular Surface and Adnexa: A Case Series.. Investigative Ophthalmology & Visual Science. 60(9). 3574–3574.

11.

Rong, Andrew J., et al.. (2018). Subperiosteal fibroma of the orbit. Orbit. 37(5). 378–380. 2 indexed citations

12.

Fernandez, Maria Paula, et al.. (2016). Histopathologic Characterization of the Expression of Vascular Endothelial Growth Factor in a Case of Retinopathy of Prematurity Treated With Ranibizumab. American Journal of Ophthalmology. 176. 134–140. 4 indexed citations

13.

Jager, Martine J., et al.. (2016). Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).. PubMed. 114. T5–T5. 73 indexed citations

14.

Fischer, Oliver M., et al.. (2016). Sustained Efficacy of Targeted Therapy with Vemurafenib in BRAF (V600e) - Mutated Erdheim - Chester Disease. 1(1). 1 indexed citations

15.

Tao, Aizhu, Jianhua Wang, Qi Chen, et al.. (2011). Topographic Thickness of Bowman's Layer Determined by Ultra-High Resolution Spectral Domain–Optical Coherence Tomography. Investigative Ophthalmology & Visual Science. 52(6). 3901–3901. 75 indexed citations

16.

Flynn, Harry W., Andrew A. Moshfeghi, Philip J. Rosenfeld, et al.. (2011). Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Antagonists: A Six-Year Experience at a University Referral Center. Investigative Ophthalmology & Visual Science. 52(14). 5926–5926. 7 indexed citations

17.

Aziz‐Sultan, Mohammad Ali, et al.. (2010). Supraselective Intra-Ophthalmic Artery Chemotherapy: Evaluation of Treatment Related Complications in Advanced Retinoblastoma. Investigative Ophthalmology & Visual Science. 51(13). 1579–1579. 1 indexed citations

18.

Fung, Anne E., Geeta A. Lalwani, Stephan Michels, et al.. (2007). Characteristics of Patients Losing Vision at Year 1 of the PrONTO Study. Investigative Ophthalmology & Visual Science. 48(13). 4579–4579. 1 indexed citations

19.

Benz, Matthew S., et al.. (2003). Endophthalmitis Caused by Mycobacterium chelonae abscessus After Intravitreal Injection of Triamcinolone. Archives of Ophthalmology. 121(2). 271–271. 93 indexed citations

20.

Miller, Darlene, et al.. (2003). The Association of Exudative Age-Related Macular Degeneration With Prior Infection. Investigative Ophthalmology & Visual Science. 44(13). 1747–1747. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact